肺纤维化需要PAI-1与索尔提林相关受体1的相互作用
Thomas H Sisson1, John J Osterholzer1, Lisa Leung2
1Division of Pulmonary & Critical Care Medicine, University of Michigan Medical School, Ann Arbor, United States of America.
JCI insight
|April 29, 2025
概括
血原激活剂抑制剂1 (PAI-1) 通过与林相关受体1 (SorLA) 的新型相互作用驱动肺纤维化,而不是维特龙菌素. 索拉缺乏能防止肺部痕,这意味着索拉是异常性肺纤维化 (IPF) 的治疗标.
科学领域:
- 肺部医学 肺部医学
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 之前,人们认为等离子体激活剂抑制剂1 (PAI-1) 通过依赖于维特罗涅的机制促进肺纤维化.
- 这项研究调查了驱动PAI-1-介导肺纤维化的潜在分子相互作用.
研究的目的:
- 阐明PAI-1促进肺纤维化的机制.
- 为了确定涉及肺纤维化的新型PAI-1结合伙伴.
- 评估林相关受体1 (SorLA) 作为异常性肺纤维化 (IPF) 的潜在治疗标.
主要方法:
- 使用了两种不同的小鼠纤维化模型和缺乏VTN的小鼠.
- 采用无偏的蛋白质组方法来识别PAI-1结合伙伴.
- 使用遗传缺陷模型研究了SorLA在肺纤维化中的作用.
- 分析了人类IPF的SorLA和PAI-1蛋白水平和相关性.
- 进行了共聚焦显微镜,以评估蛋白质的同位化和细胞吸收.
主要成果:
- 维特罗涅 (VTN) 不需要PAI-1驱动肺部痕.
- 索尔林相关受体1 (SorLA) 被确定为纤维化肺部的关键PAI-1结合伙伴.
- 在小鼠模型中,SorLA缺陷可以防止肺部痕.
- 索拉对PAI-1来说是必不可少的,它可以促进肺部痕.
- 索拉和PAI-1水平都在人体IPF组织中升高和相关.
- 索拉的表达增强了PAI-1细胞吸收和局部化.
结论:
- PAI-1通过涉及SORLA的维特罗涅丁独立机制促进肺纤维化.
- 索拉促进了PAI-1驱动的肺痕.
- 索拉代表了治疗IPF的潜在治疗标.
相关概念视频
Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...


